GENETIC TECHNOLOGIES LIMITED — Board/Management Information 2003

Aug 31, 2003

1 September 2003

The Manager Company Announcements Office Australian Stock Exchange Limited Exchange Centre 20 Bridge Street Sydney NSW 2000

Dear Sir.

Professor Simon Easteal joins GTG Scientific Advisory Committee

Genetic Technologies Limited ("GTG") is pleased to announce that Professor Simon Easteal, an expert in the application of genetics to the management of health, has joined the GTG Scientific Advisory Committee. His main role will be to advise GTG on the use of newly emerging genetic knowledge to help detect and prevent diseases in humans, animals and plants.

Professor Easteal is internationally recognised as a geneticist and as a biological informatics specialist. He heads the Human Genetics Group at the Australian National University, Canberra, where he is also the co-director of the Centre for Bioinformation Science. He also edits the prestigious journal Molecular Biology and Evolution, and is on the Advisory Board to the Sydney University Biological Informatics and Technology Centre. He has been a member of the Human Diversity Subcommittee of the Human Genome Organisation, and an advisor to the Federal Government's Bioinformatics Industry Opportunity Taskforce.

Professor Easteal is author of two books and over 100 scientific papers. He has done research into areas of great importance in health, including the genetics of complex diseases such as depression, substance abuse, and prostate and breast cancer, diseases which collectively affect many millions of people globally. He has won several awards for his research, including the prestigious Julian Wells Medal for outstanding contributions to our understanding of gene action, genome organization and genomic evolution.

His additional areas of interest include recent research into the genetic basis of human sports performance. Accordingly, he has served as a member of the Research Committee of the Australian Institute of Sport (AIS). He has also published widely on the use of genetic evidence in the context of law and criminal justice.

Professor Easteal will assist GTG in the identification and implementation of opportunities for genetic testing and disease monitoring in humans, animals and plants. He will also play a major role in guiding the existing and future commercial and basic research projects funded by the Company. He will advise GTG on how to best leverage the biological information management aspects of these research projects, and on the optimal use of bioinformatics in the management of the disease testing and monitoring programs. In addition, his expertise will support GTG's establishment of an independent forensic testing facility in Australia.

We are delighted to have Professor Easteal join the GTG Scientific Advisory Committee.

Yours faithfully,

Dr Mervyn Jacobson Executive Chairman